Stroke, Vol 17, 404-409, Copyright © 1986 by American Heart Association
HP Adams Jr, CP Olinger, WG Barsan, MJ Butler, NR Graff-Radford, TG Brott, J Biller, H Damasio, T Tomsick and M Goldberg
A dose-escalation study was performed in 27 patients to determine the
highest safe and potentially optimal dose of naloxone for treatment of
acute cerebral ischemia. All patients received a bolus of naloxone followed
by a continuous 24 hour infusion at an hourly rate 50% of the bolus.
Loading doses ranged from 2.5 to 200 mg/m2. Total patient doses ranged from
52.3 to 4978 mg. No major dose-related side effects occurred. This study
was not designed to determine naloxone's efficacy in stroke, but transient
or sustained improvement was observed in 13 patients. Three patients'
neurological condition worsened within three hours after the naloxone was
discontinued. Our experience suggests that further therapeutic trials of
naloxone are worthwhile.
ARTICLES
A dose-escalation study of large doses of naloxone for treatment of patients with acute cerebral ischemia
This article has been cited by other articles:
![]() |
L. B. Goldstein, C. Bertels, and J. N. Davis Interrater Reliability of the NIH Stroke Scale Arch Neurol, June 1, 1989; 46(6): 660 - 662. [Abstract] [PDF] |
||||
![]() |
L. R. Wechsler Analytic Reviews : Potential New Therapies for Acute Ischemic Stroke J Intensive Care Med, September 1, 1988; 3(5): 258 - 264. [Abstract] [PDF] |
||||
![]() |
M. A. Sloan Thrombolysis and Stroke: Past and Future Arch Neurol, July 1, 1987; 44(7): 748 - 768. [Abstract] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1986 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |